Cancer Super-Survivors May Hold Keys to New Treatments

Inside Cure51

Publication Date:

"The stomach pains had persisted for a couple of months when Yann Bizien, a business developer in the software industry who was 35 at the time, finally ended up in the emergency room at a hospital in Versailles, France. He had already seen his family doctor who prescribed antacid medication. But the true diagnosis, when it came, was devastating: Pancreatic cancer, which had spread to his liver. Bizien, a married father of a young child who exercised regularly and did not smoke, realized that if the disease followed its normal course, he would have just months to live."

Read more

UNTIL ALL SURVIVE.

From frontline caregivers and patients to researchers and media voices, we bring diverse perspectives together to advance cancer research. Let’s talk.

UNTIL ALL SURVIVE.

Rosalind is an independent, proprietary Cure51 clinical study and is not affiliated with any external AI models or products.

©2024 Cure51, All Rights Reserved

©2026 Cure51, All Rights Reserved

Rosalind is an independent, proprietary Cure51 clinical study and is not affiliated with any external AI models or products.